---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-031184"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:42:08.758706+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharma shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting

## Summary
- Nine directors elected; average support ~97% of votes cast (excluding broker non-votes).
- EisnerAmper LLP ratified as independent auditor for FY 2023 with 70.8M for, 901.6K against.
- Non-binding say-on-pay approved: 53.8M for, 10.5M against, 18.4K abstentions.
- Meeting held June 22, 2023; ~89% of outstanding shares represented.

## SEC filing metadata
- accession: 0001140361-23-031184
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/0001140361-23-031184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/brhc20054840_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-031184
- JSON: https://secwatch.observer/filing/0001140361-23-031184.json
- Plain text: https://secwatch.observer/filing/0001140361-23-031184.txt

## Key facts
- Shareholder Votes
  ROCKET PHARMACEUTICALS, INC. shareholders approved Election of Directors at the 2023-06-22 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The Company’s stockholders approved the election of nine directors to the Company’s Board of Directors (“Board”) by the following votes:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/0001140361-23-031184-index.htm
- Shareholder Votes
  ROCKET PHARMACEUTICALS, INC. shareholders approved Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2023-06-22 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy statement for the 2023 Annual Meeting of Stockholders pursuant to Section 14A of the Exchange Act, including the Compensation Discussion and Analysis, the Summary Compensation Table, and the narrative disclosures that accompany the compensation tables. The final votes were:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/0001140361-23-031184-index.htm
- Shareholder Votes
  ROCKET PHARMACEUTICALS, INC. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-06-22 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: The Company’s stockholders ratified the appointment of EisnerAmper LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2023 by the following votes:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036123031184/0001140361-23-031184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.